Preparation and Feasibility of Exams for Expected Studies
NCT ID: NCT05698810
Last Updated: 2025-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
150 participants
INTERVENTIONAL
2023-03-20
2033-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EEG Monitoring for PERFormance Anticipation
NCT03233282
Study on Neurocognitive Plasticity in Patients With Focal and Drug-resistant Epilepsy
NCT03543267
Light Needle Positioning Robot Under MRI Guidance
NCT02360241
Localizing the Epileptogenic Zone With High Resolution Electroencephalography
NCT01090934
National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug
NCT03278210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The expected results of this protocol are mainly the dimension of experimental paradigms and the optimization of the clinical management of subjects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Volunteers
tests
CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability
tests
CE marked Medical Device Magnetic Resonance Imaging (MRI) usability
tests
CE marked Medical Device ElectroEncephaloGraphy (EEG) usability
tests
CE marked Medical Device ElectroCardioGraphy (ECG) usability
tests
Parkinson's Disease patients
tests
CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability
tests
CE marked Medical Device Magnetic Resonance Imaging (MRI) usability
tests
CE marked Medical Device ElectroEncephaloGraphy (EEG) usability
tests
CE marked Medical Device ElectroCardioGraphy (ECG) usability
tests
Para/tetraplegic Patients
tests
CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability
tests
CE marked Medical Device Magnetic Resonance Imaging (MRI) usability
tests
CE marked Medical Device ElectroEncephaloGraphy (EEG) usability
tests
CE marked Medical Device ElectroCardioGraphy (ECG) usability
tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CE marked Medical Device MagnetoEncephaloGraphy (MEG) usability
tests
CE marked Medical Device Magnetic Resonance Imaging (MRI) usability
tests
CE marked Medical Device ElectroEncephaloGraphy (EEG) usability
tests
CE marked Medical Device ElectroCardioGraphy (ECG) usability
tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated to a social security scheme
* Free and informed consent signed
Exclusion Criteria
* Subject deprived of liberty by a judicial or administrative decision, or major subject subject to a legal protection measure (guardianship, curatorship and safeguarding of justice) referred to in Articles 1121-6 to 1121-8 of the Public Health Code.
* Subject who would receive more than 4500 euros in compensation because of his participation in other research involving the human person in the 12 months preceding this study.
* Pregnant woman, parturient, nursing mother (Article 1121-5 of the Public Health Code)
* Subject not reachable urgently.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Commissariat A L'energie Atomique
OTHER_GOV
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinatec Cea/Chuga
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38RC22.0130
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.